Registry update — unassessed
Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
Trial registry update: COMPLETED. No results reported in the supplied registry record.
RCTNotable significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 28, 2021 · Discovered: Sep 15, 2026 · Assessed: — · Historical research backfill
What it does not prove
- No findings are reported in the available material, so no causal or preventive effects can be evaluated.
- The sample size and effect sizes are not provided, preventing assessment of statistical power or clinical significance.
- As an abstract-only source, this does not present the full study protocol, outcomes, or any completed analyses.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- Men and women with Metabolic syndrome (MetS)
- Primary outcome
- Prevention of age-related chronic non-communicable diseases (ArCD)
- Effect size
- —
- Significance
- Not reported
- Journal
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Published
- Sep 28, 2021
Sources
Primary source
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.
Phase III randomized controlled trial on men and women with Metabolic syndrome (MetS) to test the hypothesis that comprehensive life-style changes and/or metformin treatment prevent age-related chronic non-communicable diseases (ArCD).
The aim of the present study is to evaluate the effect of a comprehensive life-style intervention (including moderate physical activity and Mediterranean/macrobiotic diet with moderate calorie and protein restriction), and of treatment with Metformin (a calorie restriction mimetic drug) for the prevention of ArCD.
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.